This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Diabetes Mellitus  • Hypertension  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Dr Bakris and colleagues¹ comparing the metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension found that insulin sensitivity improved with carvedilol (–9.1%; P = .004) but not metoprolol (–2.0%; P = .48), with a between-group difference of –7.2% (95% confidence interval [CI], –13.8% to –0.2%). The reference the article cites supporting the use of the Homeostasis Model Assessment–Insulin Resistance (HOMA-IR) as the tool to measure insulin resistance was the study by Haffner et al.² This was a prospective study assessing predictors of development of diabetes mellitus in 3.5 years of follow-up. Jayagopal et al³ studied the variation of HOMA indices and showed that to consider a change of HOMA as clinically significant, the new value must represent at least a 90% increase or a 47% decrease. The mean improvement in HOMA-IR of 9% in the present study may . . . [Full Text of this Article]

Edgard Gonzalez-Feldman, MD
egonzal2@hfhs.org
Endocrinology Division
Henry Ford Hospital
Detroit, Mich

RELATED ARTICLES

Carvedilol, Metoprolol, and Insulin Resistance—Reply
David S. Bell and George L. Bakris
JAMA. 2005;293(10):1190.
EXTRACT | FULL TEXT  

Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial
George L. Bakris, Vivian Fonseca, Richard E. Katholi, Janet B. McGill, Franz H. Messerli, Robert A. Phillips, Philip Raskin, Jackson T. Wright, Jr, Rosemary Oakes, Mary Ann Lukas, Karen M. Anderson, David S. H. Bell, and for the GEMINI Investigators
JAMA. 2004;292(18):2227-2236.
ABSTRACT | FULL TEXT